Denali Therapeutics Inc. Deferred Tax Assets, Property, Plant and Equipment
Denali Therapeutics Inc. (DNLI) had Deferred Tax Assets, Property, Plant and Equipment of $8.59 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Property, Plant and Equipment $8.59M.
- 2024-12-31: Deferred Tax Assets, Property, Plant and Equipment $6.67M.
- 2023-12-31: Deferred Tax Assets, Property, Plant and Equipment $0.00.
| Period end | Deferred Tax Assets, Property, Plant and Equipment |
|---|---|
| 2025-12-31 | $8.59M 10-K · filed 2026-02-26 |
| 2024-12-31 | $6.67M 10-K · filed 2026-02-26 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |